These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8795394)

  • 1. Effect of L-cysteine on some urinary risk factors in experimental hyperoxaluric rats.
    Saravanan N; Senthil D; Varalakshmi P
    Br J Urol; 1996 Jul; 78(1):22-4. PubMed ID: 8795394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of banana stem extract on urinary risk factors for stones in normal and hyperoxaluric rats.
    Poonguzhali PK; Chegu H
    Br J Urol; 1994 Jul; 74(1):23-5. PubMed ID: 8044524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria.
    Selvam R; Kalaiselvi P; Govindaraj A; Bala Murugan V; Sathish Kumar AS
    Pharmacol Res; 2001 Jan; 43(1):89-93. PubMed ID: 11207071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of (L)-cysteine and (L)-2-oxothiazolidine-4-carboxylic acid (OTZ) on urinary oxalate excretion: studies using a hyperoxaluric rat model.
    Baker PW; Rofe AM; Bais R
    J Urol; 1998 Jun; 159(6):2177-81. PubMed ID: 9598565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of the oxalate precursors on the experimental calcium oxalate urolithiasis].
    Morozumi M; Ogawa Y; Tanaka T; Yamaguchi K; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1987 Jun; 78(6):1025-31. PubMed ID: 3682493
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of hyperoxaluria in the formation of calcium oxalate urinary calculi, and its association with other biochemical measurements.
    Grases F; Conte A; Coll R; Genestar C
    Scand J Urol Nephrol; 1990; 24(3):211-3. PubMed ID: 2237298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the oxalate precursors on experimental calcium oxalate urolithogenesis in rats: acute and chronic administration].
    Morozumi M; Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1022-7. PubMed ID: 7596078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria.
    Vidya L; Varalakshmi P
    Fitoterapia; 2000 Sep; 71(5):535-43. PubMed ID: 11449502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sulphated polysaccharides on erythrocyte changes due to oxidative and nitrosative stress in experimental hyperoxaluria.
    Veena CK; Josephine A; Preetha SP; Varalakshmi P
    Hum Exp Toxicol; 2007 Dec; 26(12):923-32. PubMed ID: 18375635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Morozumi M
    J Urol; 1990 Aug; 144(2 Pt 1):385-9. PubMed ID: 2374212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Tanaka T; Morozumi M
    J Urol; 1986 May; 135(5):1057-60. PubMed ID: 3007782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The etiology of urolithiasis in Udaipur (western part of India).
    Pendse AK; Singh PP
    Urol Res; 1986; 14(2):59-62. PubMed ID: 3727215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.